Haleon (HLN) Gains from Investment Securities (2022 - 2023)
Haleon (HLN) posted Gains from Investment Securities of $8.7 million for Q4 2023, up 346.91% on a QoQ basis from -$3.5 million in Q4 2022, and up 346.91% year-over-year from $1.9 million in Q4 2022.
Haleon (HLN) Gains from Investment Securities (2022 - 2023) Analysis & Trends
Haleon's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $8.7 million for Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 8.69 Mn |
| Dec 31, 2023 | 8.69 Mn |
| Dec 31, 2022 | -3.52 Mn |
| Dec 31, 2022 | -3.52 Mn |